Fibromyalgia

Autoimmune diseases are on the rise. Both Fibromyalgia and Chronic Fatigue are autoimmune diseases. The fact is based upon new studies which show that immune tests are abnormal in both these conditions. Both of these diseases tend to occur in people who have other autoimmune diseases.

There are many ways to treat Fibromyalgia and Chronic Fatigue Syndrome here we are presenting the immunological features of these conditions. Where you can diagnose them by a blood tests and treat them by IVIg antibotics, electronic aids, vitamins, herbals or diet (see the diet page).

A person is supposed to have Fibromyalgia if they have body pain in all or one half or all of the body for at least six months. They have tender areas ito touch n the neck, back, hips, shoulders, elbows and knees.. The pain usually gets worse when a storm front is approaching and the barometer falls or early in the morning. This is associated with body stiffness worst in the morning. Pain usually tend to start on the left side of the body with complaints of vague numbness. These spells of numbness then spread to the other side of the body.

A person with Chronic Fatigue usually feel excessively tired. The fatigue is so severe that they have difficulty doing things at home. Both Chronic Fatigue and Fibromyalgia can occur in the same patient at the same time. With chronic fatigue patients tend to have excessive infections like sinusitis, flu, bronchitis or runny nose.

Fibromyalgia and Chronic Fatigue Syndrome are extremely common chronic condition . The current etiology is considered to be immune deficiency, characteristic alterations in the pattern of sleep and changes. The diagnosis is clinical and is characterized by widespread pain, tender points and, commonly, conditions such as chronic fatigue, sleep issues and depression. The diagnosis can be confirmed by doing a IgG and IgG sublass screen. Treatment is is by using IVIg, although experience and small clinical studies have proved the efficacy IVIg. Other less well-studied measures, such as trigger point treatment, also appear to be helpful. Management relies heavily on the physician's supportive counseling skills and willingness to try novel strategies in refractory cases described below.

Fibromyalgia is a immunologial neurological and rheumatologic condition characterized by spontaneous, widespread soft tissue pain, sleep disturbance, fatigue and extensively distributed areas of tenderness known as tender points. Estimates of prevalence are 3.4 percent for women and 0.5 percent for men.¹

Pathophysiology

While the cause of fibromyalgia is currently considered by some to be a a immune mediated disease in some cases assossiated with a IgG subclass deficiency.

Diagnosis

Fibromyalgia should be considered in any patient with musculoskeletal pain that is unrelated to a clearly defined anatomic lesion. Making the diagnosis of fibromyalgia depends on findings from the history and physical examination rather than on diagnostic testing.

In 1990, the American College of Rheumatology (ACR) established criteria for classifying patients with fibromyalgia.⁹ However, failure to meet these criteria does not absolutely exclude the possibility of fibromyalgia.

As with other rheumatologic disorders, fibromyalgia:

Is established on the basis of clinical observations.
Is a condition with signs and symptoms that exist on a continuum.
Often requires observation over time to firmly establish the diagnosis.
Some patients will have low IgG levels or low IgG subclass levels,

History

Widespread pain is characteristic of fibromyalgia. Although not all areas may be involved simultaneously, pain may occur in the occiput, neck, shoulders, thoracic and lumbar spine, paraspinous regions, buttocks, hips, elbows and knees. People complain of pain, knots and hearing noises when they move the neck or other joints. The complaints of numbness are vague and usually cross anatomic boundaries.

Physical Examination

Examination will reveal areas of pain on palpation but without the classic inflammatory signs of redness, swelling and heat in the joints and soft tissue. Although tender points are found in many different locations, the ACR has selected 18 sites that are more characteristic for fibromyalgia (Figure 1). To be classified with a definitive diagnosis of fibromyalgia, the patient must have tenderness on palpation at 11 of the 18 sites and a history as defined in Table 1, although patients with fewer than 11 sites still may have fibromyalgia. The number of tender points may change over time.

Skill in palpation of tender points is critical to establishing a diagnosis of fibromyalgia. Physical findings encountered during palpation of the soft tissues include tender points, changes in skin texture, increased resting muscle tension and changes in the texture of the subcutaneous tissue. The muscles are at times felt to be stiff and hard. There may be reduced range of motion in the joints.

TABLE 1
American College of Rheumatology Criteria for Classification of Fibromyalgia

Widespread pain for at least three months, defined as the presence of all of the following:: Pain on the right and left sides of the body
Pain above and below the waist (including shoulder and buttock pain)
Pain in the axial skeleton (cervical, thoracic or lumbar spine, or anterior chest)
Pain on palpation in 11 of the sites shown in the above chart.

Treatment

Because the symptoms of fibromyalgia wax and wane, treatment (as with that of other chronic autoimmune diseases) is an ongoing process rather than management of a single episode. Flare-ups often exacerbate the patient's underlying stress. Furthermore, stress can also precipitate flare-ups of fibromyalgia. Physicians should spend some time eliciting and hearing the ongoing narrative of the struggle of living with a chronic disease and attempt to ameliorate the effects of the symptoms on the patient's quality of life.

For the treatment of irritable bowel syndrome just ask the person to eat small portions of diet 6-7 times a day. Thus they cannot have meals but only snacks. All FMS syndrome should go on a celiac diet to try to get rid of the disease please read this link.

People with Chronic Fatigue cannot do over activity. If they do they will have to pay for it by fatigue. Then they will have increased fatigue on the next few days. Due to immune dysfunction they cannot metabolize in the muscles.

A course of doxycycline will fully reverse m taken one tablet daily at night for minimum of three months. Alternative treatment is using a Tens unit on both hands for thirty minutes a day for almost a year , This gets rid of the pain and also the disease it self by the electronic pulses. After application a fatigue is felt. Please read the link on electrical stimulation . For those who want even a simpler treatment should try hydrogen peroxide.

In non responsive patients IVIg is used for full recovery following are some research studies. We provide full approval of IVIg from your insurance for your disease and delivery of the product to your home. With assistance to full recovery. Contact us from the services section.

To become a expert just read our e-book with all the protocols or we offer for $1.99 complete protocol for FMS & CFS treatment at home.

Am J Med. 1990 Nov;89(5):561-8.

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

Lloyd A, Hickie I, Wakefield D, Boughton C, Dwyer J.

Department of Infectious Diseases, Prince Henry Hospital, Sydney, Australia.
CONCLUSION: Immunomodulatory treatment with immunoglobulin is effective in a significant number of patients with CFS, a finding that supports the concept that an immunologic disturbance may be important in the pathogenesis of this disorder.

PMID: 2146875 [PubMed - indexed for MEDLINE]

Clin Infect Dis. 2003 May 1;36(9):e100-6. Epub 2003 Apr 22.

Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.

Kerr JR, Cunniffe VS, Kelleher P, Bernstein RM, Bruce IN.

Department of Microbiology, Royal Brompton Hospital, Imperial College London,

Three cases of chronic fatigue syndrome (CFS) that followed acute parvovirus B19 infection were treated with a 5-day course of intravenous immunoglobulin (IVIG; 400 mg/kg per day), the only specific treatment for parvovirus B19 infection. We examined the influence of IVIG treatment on the production of cytokines and chemokines in individuals with CFS due to parvovirus B19. IVIG therapy led to clearance of parvovirus B19 viremia, resolution of symptoms, and improvement in physical and functional ability in all patients, as well as resolution of cytokine dysregulation.
PMID: 12715326 [PubMed - indexed for MEDLINE]